GG
EXAS

Gofen & Glossberg’s Exact Sciences EXAS Stock Holding History

Gofen & Glossberg’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$366K Hold
7,400
– – 0.01% 397
2022
Q3 		$240K Hold
7,400
– – 0.01% 458
2022
Q2 		$291K Hold
7,400
– – 0.01% 421
2022
Q1 		$517K Buy
7,400
+700
+10% +$51.2K 0.01% 335
2021
Q4 		$521K Hold
6,700
– – 0.01% 351
2021
Q3 		$640K Hold
6,700
– – 0.02% 299
2021
Q2 		$833K Hold
6,700
– – 0.02% 260
2021
Q1 		$883K Hold
6,700
– – 0.02% 246
2020
Q4 		$888K Sell
6,700
-31
-0.5% -$3.75K 0.02% 243
2020
Q3 		$686K Sell
6,731
-1,000
-13% -$86.4K 0.02% 254
2020
Q2 		$672K Hold
7,731
– – 0.02% 243
2020
Q1 		$448K Sell
7,731
-150
-2% -$12.2K 0.02% 279
2019
Q4 		$729K Sell
7,881
-412
-5% -$36.2K 0.02% 245
2019
Q3 		$749K Buy
8,293
+18
+0.2% +$2.05K 0.03% 235
2019
Q2 		$977K Sell
8,275
-100
-1% -$10.1K 0.03% 217
2019
Q1 		$725K Buy
8,375
+150
+2% +$12.8K 0.03% 228
2018
Q4 		$519K Hold
8,225
– – 0.02% 255
2018
Q3 		$649K Buy
8,225
+375
+5% +$24.5K 0.02% 249
2018
Q2 		$469K Hold
7,850
– – 0.02% 293
2018
Q1 		$317K Sell
7,850
-1,150
-13% -$56.1K 0.01% 354
2017
Q4 		$473K Sell
9,000
-200
-2% -$10.7K 0.02% 311
2017
Q3 		$434K Hold
9,200
– – 0.02% 320
2017
Q2 		$325K Sell
9,200
-1,500
-14% -$46.3K 0.01% 365
2017
Q1 		$253K Hold
10,700
– – 0.01% 399
2016
Q4 		$143K Hold
10,700
– – 0.01% 433
2016
Q3 		$199K Buy
10,700
+100
+0.9% +$1.76K 0.01% 417
2016
Q2 		$130K Buy
+10,600
New +$79.8K 0.01% 428
2015
Q4 		– Sell
-11,200
Closed -$201K – 453
2015
Q3 		$201K Hold
11,200
– – 0.01% 416
2015
Q2 		$333K Hold
11,200
– – 0.01% 335
2015
Q1 		$247K Buy
+11,200
New +$284K 0.01% 399

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Gofen & Glossberg's EXAS Position: Q4 2022 in Review

Gofen & Glossberg held its Exact Sciences (EXAS) position steady in Q4 2022 at 7,400 shares worth $366K. The position accounts for 0.01% of the portfolio, ranked #397.

Gofen & Glossberg first reported a position in EXAS in Q1 2015 and has held it in 30 quarters since. The position peaked at $977K in Q2 2019. 551 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Gofen & Glossberg held 7,400 shares of Exact Sciences worth $366K as of Q4 2022.
  • Gofen & Glossberg left its Exact Sciences share count unchanged in Q4 2022.
  • Exact Sciences made up 0.01% of Gofen & Glossberg's portfolio in Q4 2022, its #397 holding.
  • Gofen & Glossberg first reported a position in Exact Sciences in Q1 2015 and has held it in 30 quarters since.
  • Gofen & Glossberg's Exact Sciences position peaked at $977K in Q2 2019.
  • 551 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.